Summit Therapeutics Inc. (SMMT) stock
SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.67−1.15 (-9.73%)
Close on Nov 17, 2026Market cap $8.51BP/E –Yield –
Summit Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Summit Therapeutics's EV/EBITDA was 25.0× on Jan 31, 2022, against 15.7× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 25.0× | −8.9 |
| 2021 | Dec 31, 2021 | 33.8× | +25.4 |
| 2020 | Dec 31, 2020 | 8.5× | – |
See a number that looks wrong?